deferasirox has been researched along with natriuretic peptide, brain in 1 studies
| Studies (deferasirox) | Trials (deferasirox) | Recent Studies (post-2010) (deferasirox) | Studies (natriuretic peptide, brain) | Trials (natriuretic peptide, brain) | Recent Studies (post-2010) (natriuretic peptide, brain) |
|---|---|---|---|---|---|
| 832 | 136 | 572 | 16,317 | 1,867 | 8,887 |
| Protein | Taxonomy | deferasirox (IC50) | natriuretic peptide, brain (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 1 | Homo sapiens (human) | 0.006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delaporta, P; Goussetis, E; Hantzi, E; Kattamis, A; Ladis, V; Margeli, A; Papassotiriou, I; Sergounioti, A | 1 |
1 other study(ies) available for deferasirox and natriuretic peptide, brain
| Article | Year |
|---|---|
Cystatin C levels in patients with beta-thalassemia during deferasirox treatment.
Topics: Acute-Phase Proteins; Adolescent; Adult; Benzoates; beta-Thalassemia; Child; Cystatin C; Deferasirox; Female; Glomerular Filtration Rate; Humans; Iron Chelating Agents; Lipocalin-2; Lipocalins; Male; Natriuretic Peptide, Brain; Peptide Fragments; Proto-Oncogene Proteins; Triazoles; Young Adult | 2010 |